⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28977853 | 1.00 | — | — | |
| SCHEMBL25955 | 1.00 | — | — | |
| SCHEMBL9517101 | 0.97 | — | — | |
| Beta-Alanine SCHEMBL7631991 | 0.81 | CYP1A2 (0.41) | — | |
| Pyridine SCHEMBL28789704 | 0.81 | TSHR (0.39) | — | |
| SCHEMBL3864044 | 0.73 | — | — | |
| SCHEMBL5618632 | 0.73 | — | — | |
| SCHEMBL27558180 | 0.71 | — | — | |
| SCHEMBL3925246 | 0.71 | — | — | |
| SCHEMBL7350591 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 569 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595314-B2 | Antibody specific for GPC3 and methods of use thereof | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2026-04-07 | — | — | US | claimed |
| US-20240343818-A1 | Antibodies Having Humanized Framework Regions | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2024-10-17 | — | — | US | claimed |
| EP-3571223-B1 | ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF | VISTERRA INC (US) | 2024-09-18 | — | — | EP | claimed |
| EP-4392456-A2 | ANTIBODIES HAVING HUMANIZED FRAMEWORK REGIONS | R.P. Scherer Technologies, LLC (US) | 2024-07-03 | — | — | EP | claimed |
| CN-118119644-A | Antibodies with humanized framework regions | R.P.谢勒技术有限责任公司 | 2024-05-31 | — | — | CN | claimed |
| US-11970546-B2 | Antibody specific for Mucin-1 and methods of use thereof | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-04-30 | — | — | US | claimed |
| CN-114315794-B | 5-aliphatic heterocyclic group-3-hydroxypyridine-2-formylglycine compound, preparation method, pharmaceutical composition and application | 中国药科大学 | 2024-02-27 | — | — | CN | claimed |
| US-11890319-B2 | Antibody molecule-drug conjugates and uses thereof | Visterra, Inc. (US) | 2024-02-06 | — | — | US | claimed |
| CN-116322770-A | Antibodies specific for mucin-1 and methods of use thereof | R·P·舍勒科技有限责任公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4188432-A1 | ANTIBODY SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF | R.P. Scherer Technologies, LLC (US) | 2023-06-07 | — | — | EP | claimed |
| US-20110287041-A1 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-11-24 | — | — | US | claimed |
| US-20110250704-A1 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-10-13 | — | — | US | claimed |
| US-7985783-B2 | Aldehyde tags, uses thereof in site-specific protein modification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-07-26 | — | — | US | claimed |
| CN-102027110-A | Preparation of active highly phosphorylated human lysosomal sulfatase enzyme and application thereof | BIOMARIN PHARM INC | 2011-04-20 | — | — | CN | claimed |
| WO-2010096394-A2 | ALDEHYDE-TAGGED PROTEIN-BASED DRUG CARRIERS AND METHODS OF USE | REDWOOD BIOSCIENCES, INC. (US) | 2010-08-26 | — | — | WO | claimed |
| US-20100210543-A1 | Aldehyde-Tagged Protein-Based Drug Carriers and Methods of Use | REDWOOD BIOSCIENCE, INC. | 2010-08-19 | — | — | US | claimed |
| CN-101444621-A | Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (FGE) | TRANSKARYOTIC THERAPIES INC (US) | 2009-06-03 | — | — | CN | claimed |
| CN-1759176-A | Diagnosis and treatment of multiple sulfatase deficiency and other disorders using formyl-glycine generating enzyme (FGE) | TRANSKARYOTIC THERAPIES INC (US) | 2006-04-12 | — | — | CN | claimed |
| EP-1592786-A2 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | Transkaryotic Therapies, Inc. (US) | 2005-11-09 | — | — | EP | claimed |
| WO-2004072275-A2 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | TRANSKARYOTIC THERAPIES, INC. (US) | 2004-08-26 | — | — | WO | claimed |